Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Time to read between the lines again

Re: Time to read between the lines again

posted on Jul 16, 2009 01:17PM

Keep in mind that while we wait for PDSG generated revenue, PDSG overhead is growing. Might the news regarding PDSG revenue projection have caused the BOD to reconsider RG's plan? That might explain the audit committee hiring Baroni, not RG. Perhaps BOD wants to know if interested parties exist and what kind of $ we might be talking about, before committing to a sale. BOD may have come to the conclusion that it is no longer feasible to support PDSG and the MMP. And the MMP must take priority.

Well that is my reading of the tea leaves, FWIW

Also have been buying at .115.

Opty

Share
New Message
Please login to post a reply